RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th
RenovoRx, Inc., a Nasdaq-listed life sciences company, announced that its CEO and CFO will present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20, 2026. The presentation will highlight record first-quarter 2026 revenue from their FDA-cleared RenovoCath drug-delivery device, growing adoption in high-volume cance…